share_log

BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $55

BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $55

BMO Capital維持Ingevity的市場表現,將目標股價上調至55美元
Benzinga ·  05/08 11:22

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Market Perform and raises the price target from $50 to $55.

BMO Capital分析師約翰·麥克納爾蒂維持Ingevity(紐約證券交易所代碼:NGVT)的市場表現,並將目標股價從50美元上調至55美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論